Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases
- PMID: 33805943
- PMCID: PMC8064370
- DOI: 10.3390/medicina57040308
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases
Abstract
The prediction and prevention of sudden cardiac death is the philosopher's stone of clinical cardiac electrophysiology. Sports can act as triggers of fatal arrhythmias and therefore it is essential to promptly frame the athlete at risk and to carefully evaluate the suitability for both competitive and recreational sports activity. A history of syncope or palpitations, the presence of premature ventricular complexes or more complex arrhythmias, a reduced left ventricular systolic function, or the presence of known or familiar heart disease should prompt a thorough evaluation with second level examinations. In this regard, cardiac magnetic resonance and electrophysiological study play important roles in the diagnostic work-up. The role of genetics is increasing both in cardiomyopathies and in channelopathies, and a careful evaluation must be focused on genotype positive/phenotype negative subjects. In addition to being a trigger for fatal arrhythmias in certain cardiomyopathies, sports also play a role in the progression of the disease itself, especially in the case arrhythmogenic right ventricular cardiomyopathy. In this paper, we review the latest European guidelines on sport cardiology in patients with cardiovascular diseases, focusing on arrhythmic risk stratification and the management of cardiomyopathies and channelopathies.
Keywords: athletes; cardiomyopathies; channelopathies; sport; sudden cardiac death.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
[ESC guidelines on sports cardiology 2020 : Which sports can be performed with heart diseases?].Herz. 2021 Feb;46(1):38-45. doi: 10.1007/s00059-020-05008-9. Epub 2020 Dec 17. Herz. 2021. PMID: 33336289 Review. German.
-
Evolving spectrum of arrhythmogenic cardiomyopathy: Implications for Sports Cardiology.Clin Cardiol. 2023 Sep;46(9):1072-1081. doi: 10.1002/clc.24069. Epub 2023 Jun 25. Clin Cardiol. 2023. PMID: 37357443 Free PMC article. Review.
-
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.Eur Heart J. 2005 Mar;26(5):516-24. doi: 10.1093/eurheartj/ehi108. Epub 2005 Feb 2. Eur Heart J. 2005. PMID: 15689345 Review.
-
Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies.Rev Recent Clin Trials. 2015;10(2):111-27. doi: 10.2174/1574887110666150407104312. Rev Recent Clin Trials. 2015. PMID: 25845953 Review.
-
Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators.Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):676-86. doi: 10.1097/01.hjr.0000239465.26132.29. Eur J Cardiovasc Prev Rehabil. 2006. PMID: 17001205
Cited by
-
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment.J Clin Med. 2024 Feb 27;13(5):1350. doi: 10.3390/jcm13051350. J Clin Med. 2024. PMID: 38592178 Free PMC article. Review.
-
Brugada Syndrome and Exercise: Is It Time for a Paradigm Change?J Cardiovasc Dev Dis. 2025 Mar 6;12(3):94. doi: 10.3390/jcdd12030094. J Cardiovasc Dev Dis. 2025. PMID: 40137092 Free PMC article. Review.
-
The safety of sports in children with inherited arrhythmia substrates.Front Pediatr. 2023 Apr 4;11:1151286. doi: 10.3389/fped.2023.1151286. eCollection 2023. Front Pediatr. 2023. PMID: 37124180 Free PMC article. Review.
-
Myocarditis in Athletes: Risk Factors and Relationship with Strenuous Exercise.Sports Med. 2024 Mar;54(3):607-621. doi: 10.1007/s40279-023-01969-z. Epub 2023 Dec 11. Sports Med. 2024. PMID: 38079080 Review.
-
Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics.Int J Mol Sci. 2022 Aug 6;23(15):8753. doi: 10.3390/ijms23158753. Int J Mol Sci. 2022. PMID: 35955883 Free PMC article. Review.
References
-
- Finocchiaro G., Papadakis M., Tanzarella G., Dhutia H., Miles C., Tome M., Behr E.R., Sharma S., Sheppard M.N. Sudden death can be the first manifestation of hypertrophic cardiomyopathy: Data from a United Kingdom Pathology Registry. JACC Clin. Electrophysiol. 2019;5:252–254. doi: 10.1016/j.jacep.2018.11.004. - DOI - PubMed
-
- Chan R.H., Maron B.J., Olivotto I., Pencina M.J., Assenza G.E., Haas T., Lesser J.R., Gruner C., Crean A.M., Rakowski H., et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evalua-tion of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130:484–495. doi: 10.1161/CIRCULATIONAHA.113.007094. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical